262.6

+1.27%↑

SAN

78.93

-0.62%↓

MRK1

110.9

+1.51%↑

SHL.DE

47.57

+0.76%↑

ARGX

649

+1.5%↑

262.6

+1.27%↑

SAN

78.93

-0.62%↓

MRK1

110.9

+1.51%↑

SHL.DE

47.57

+0.76%↑

ARGX

649

+1.5%↑

262.6

+1.27%↑

SAN

78.93

-0.62%↓

MRK1

110.9

+1.51%↑

SHL.DE

47.57

+0.76%↑

ARGX

649

+1.5%↑

262.6

+1.27%↑

SAN

78.93

-0.62%↓

MRK1

110.9

+1.51%↑

SHL.DE

47.57

+0.76%↑

ARGX

649

+1.5%↑

262.6

+1.27%↑

SAN

78.93

-0.62%↓

MRK1

110.9

+1.51%↑

SHL.DE

47.57

+0.76%↑

ARGX

649

+1.5%↑

Strona główna・Stock List・Virbac SA

Virbac SA

Closed

SectorHealthcare

325.5 0.77

Buy Sell

Overview

Share price change

24h

Current

Min

319

Max

325.5

Key metrics
By Trading Economics
Income	51M
Sales	694M
P/E Sector Avg	18.858 35.733
EPS	6.04
Dividend yield	0.43
Profit margin	7.29
Employees	6,365
EBITDA	116M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+13.89% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	0.43% 3.13%
Next Earnings	12 wrz 2025

Market Stats
By TradingEconomics
Market Cap	2.8B
Previous open	324.73
Previous close	325.5

News Sentiment

By Acuity

24%

76%

71 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

303.6 / 306.25 Support & Resistance

Virbac SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 wrz 2025, 23:59 UTC

Acquisitions, Mergers, Takeovers

Anglo American Is in Talks to Buy Teck Resources, Bloomberg Says

8 wrz 2025, 22:02 UTC

Major Market Movers

Microsoft Signs $17.4 Billion AI Deal With Nebius

8 wrz 2025, 17:01 UTC

Major Market Movers

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8 wrz 2025, 17:01 UTC

Major Market Movers

Tron Shares Rise After New Investment From Bravemorning

8 wrz 2025, 16:14 UTC

Major Market Movers

Beyond Air Shares Climb on FDA Orphan Drug Designation for Brain Cancer Treatment

8 wrz 2025, 16:13 UTC

Major Market Movers

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

8 wrz 2025, 23:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 wrz 2025, 23:12 UTC

Market Talk

Global Equities Roundup: Market Talk

8 wrz 2025, 23:12 UTC

Market Talk

Infratil's New Bull Likes Exposure to Growing Infrastructure Businesses -- Market Talk

8 wrz 2025, 22:56 UTC

Market Talk

Worst May Be Over for New Zealand Retailers -- Market Talk

8 wrz 2025, 22:23 UTC

Market Talk

Ebos's Near-Term Earnings Outlook Dims -- Market Talk

8 wrz 2025, 21:51 UTC

Market Talk

AT&T Backs Outlook After EchoStar Spectrum Purchase -- Market Talk

8 wrz 2025, 21:47 UTC

Major Market Movers

Microsoft Signs $17.4B AI Deal With Nebius

8 wrz 2025, 21:33 UTC

Acquisitions, Mergers, Takeovers

This Quantum Pure Play Is Going Public. What Infleqtion Does Differently, Says Its CEO. -- Barrons.com

8 wrz 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

MEG Energy Plans to Respond on or Before Sept 15 >MEG.T

8 wrz 2025, 21:19 UTC

Acquisitions, Mergers, Takeovers

MEG Energy Special Committee and Board Will Evaluate Revised Strathcona Offer >MEG.T

8 wrz 2025, 21:18 UTC

Acquisitions, Mergers, Takeovers

MEG Energy Acknowledges Strathcona's Intention to Revise Offer

8 wrz 2025, 20:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

8 wrz 2025, 19:33 UTC

Market Talk

Oil Futures Gain Despite Planned OPEC+ Output Increases -- Market Talk

8 wrz 2025, 19:22 UTC

Market Talk

U.S. Natural Gas Futures Settle Higher -- Market Talk

8 wrz 2025, 19:02 UTC

Market Talk

Dollar Lukewarm Amid Data Hiatus Ahead of August CPI -- Market Talk

8 wrz 2025, 18:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 wrz 2025, 18:24 UTC

Market Talk

Weaker Argentine Peso Profitable for Grain Producers -- Market Talk

8 wrz 2025, 17:29 UTC

Market Talk

Mexican Inflation Seen Little Changed in August -- Market Talk

8 wrz 2025, 16:59 UTC

Market Talk

Acquisitions, Mergers, Takeovers

SpaceX Spectrum Acquisition Will Create More Satellite Connection Supply, Verizon CEO Says -- Market Talk

8 wrz 2025, 16:36 UTC

Market Talk

Crude Futures Hold Gains After OPEC+ Output Decision -- Market Talk

8 wrz 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8 wrz 2025, 16:16 UTC

Earnings

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

8 wrz 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 wrz 2025, 16:04 UTC

Market Talk

Global Equities Roundup: Market Talk

Peer Comparison

Price change

Virbac SA Forecast

Price Target

By TipRanks

13.89% upside

12 Months Forecast

Average 369 EUR 13.89%

High 390 EUR

Low 348 EUR

Based on 2 Wall Street analysts offering 12 month price targets forVirbac SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Virbac SA - Dist in the past 3 months.

Technical Score

By Trading Central

303.6 / 306.25Support & Resistance

Recent bearish events outweigh bullish events.

All events are bullish.

Bearish events outweigh bullish events.

Sentiment

By Acuity

71 / 371 Ranking in Healthcare

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.